11 декабр 2021
1ҚАНДЛИ ДИАБЕТ БИЛАН КЕЧАДИГАН СУРУНКАЛИ ОБСТРУКТИВ ЎПКА КАСАЛЛИГИНИНГ ЎЗИГА ХОС РЕНТГЕНОЛОГИК ХУСУСИЯТЛАРИ
61b987552b7f4.pdf
MAQOLA ANNOTATSIYASI
MUALIFLAR
Teglar
Maqolani baholang
0
Maqola idintifikatorlari
DOI:
Mavjud emas
Foydalanilgan adabiyotlar
4. Samorukova E. I. Malinicheva Yu. V., Zadionchenko B. C. Obesity and metabolic disorders in patients with chronic obstructive pulmonary disease: possibilities of phenotyping. Pulmonology. 2014; 5:32-38
2. lyubavina N. A. Influence of type 2 diabetes mellitus on the clinic, immune response and microbiocenosis of the respiratory tract in patients with obstructive diseases: author's thesis ... candidate of medical Sciences N. Novgorod, 2011.
3. Russian respiratory society: Federal clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease / A. G. Chuchalin et al. / / Pulmonology. - 2014. - No. 3. - Pp. 15-54.
1. Vertkin A. L. Comorbidity in chronic obstructive pulmonary disease: the role of chronic systemic inflammation and clinical and pharmacological niches of roflumilast / / A. L. Vertkin, A. S. Skotnikov, O. M. Gubzhokova. - Attending physician. - 2013. - No. 9. - P. 34-39.
6. Diabetes among outpatients with COPD attending a university hospital / P. Rogliani [et al.] // Acta Diabetologica. – 2014. – Vol. 51. – № 6. – P. 933-40.
7. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (Updated 2018). [Electronic resource]. URL: http://goldcopd.org/. Access: 11.05.2018.
8. Global Initiative for Chronic Obstructive Lung Disease, GOLD, 2016
9. Miller J., Edwards L.D., Agusti A., Bakke P., Calverley P.M., Celli B. et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013. No. 107. R. 1376-1384.
10. Parappil, A., Depczynski, B., Collett, P., Marks G. B. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010. No. 15. P. 918-922.
11. Turdumatov Zh. A., Mardieva G. M. Aspects of verification of radiation diagnostics of chronic obstructive lung disease. Eurasian Union of Scientists (ESU) 3 (72), 2020. C43-45.
12. Ziyadullayev S., Aralov N.R., Dushanova G.A. Hla-copd and bronchial asthma markers: Commonalities and differences. International Journal of Pharmaceutical Research. -12(1).- 2020.-P. 1233-1237.
13. Хегай Л. Н. и др. СОДЕРЖАНИЕ 25-OH-ВИТАМИНА D У ФУТБОЛИСТОВ В УСЛОВИЯХ СОЛНЕЧНОЙ РАДИАЦИИ УЗБЕКИСТАНА //Actual Questions and Innovations in Science 2. – 2019. – С. 160-161.
14. Скворцова Л. А. и др. АСПЕКТЫ СПОРТИВНОЙ АДАПТОЛОГИИ ПРИ ИЗУЧЕНИИ ВИТАМИНА D 25 (OH) D У ФУТБОЛИСТОВ //От фундаментальных знаний к тонкому владению скальпелем. – 2019. – С. 51-54.
15. Скворцова Л. А., Хегай Л. Н. ОЦЕНКА ПИЩЕВОГО СТАТУСА ФУТБОЛИСТОВ СБОРНЫХ КОМАНД ПО ИНДЕКСУ МАССЫ ТЕЛА //Безопасный спорт-2019. – 2019. – С. 108-110.
16. Хегай Л. Н. ЗНАЧИМОСТЬ ВИТАМИНА D В НАУЧНОЙ СПОРТОЛОГИИ (ОБЗОР ЛИТЕРАТУРЫ) //ЎЗБЕКИСТОН МИЛЛИЙ ОЛИМПИЯ ҚЎМИТАСИ НАЦИОНАЛЬНЫЙ ОЛИМПИЙСКИЙ КОМИТЕТ УЗБЕКИСТАНА NATIONAL OLYMPIC COMMITTEE OF UZBEKISTAN. – 2019. – С. 408.
5. Couillard A. Comorbidities in COPD: a new challenge in clinical practice / A. Couillard, D. Veale, J.F. Muir // Rev Pneumol Clin. – 2011. – Vol. 67. – № 3. – P. 143-53.